SCHEMBL16237501

SCHEMBL16237501

Cc1[nH]c(C(=O)Nc2ccc(F)c(F)c2)cc1S(=O)(=O)Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.48
▸ NPC1 O15118 5/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ PLA2G7 Q13093 3/20 0.46
▸ IDH1 O75874 1/20 0.45
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ PRNP P04156 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ HTR2B P41595 1/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ENPP2 Q13822 1/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236610 0.91 NPC1 (0.49) RAB9ANPC1SMN1; SMN2PLA2G7IDH1
SCHEMBL16237029 0.88 CYP1A2 (0.41) RAB9ANPC1SMN1; SMN2PLA2G7MEN1
SCHEMBL16237067 0.87 GRM4 (0.41) RAB9ANPC1SMN1; SMN2PLA2G7IDH1
SCHEMBL16237215 0.87 CYP1A2 (0.45) RAB9ANPC1PLA2G7ALDH1A1KDM4E
SCHEMBL16237208 0.86 GRM4 (0.50) RAB9ANPC1PLA2G7MEN1KMT2A
SCHEMBL16236529 0.84 IDO1 (0.43) RAB9ANPC1SMN1; SMN2IDH1MEN1
SCHEMBL16236502 0.83 ENPP2 (0.40) RAB9ANPC1PLA2G7MEN1KMT2A
SCHEMBL16236829 0.82 CYP1A2 (0.41) RAB9ANPC1PLA2G7MEN1KMT2A
SCHEMBL16236925 0.81 CYP1A2 (0.36) RAB9ANPC1PLA2G7MEN1KMT2A
SCHEMBL16236340 0.81 ENPP2 (0.43) RAB9ANPC1SMN1; SMN2PLA2G7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997011-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Janssen Sciences Ireland UC (IE) 2016-03-23 — — EP disclosed
WO-2014184350-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN R&D IRELAND (IE) 2014-11-20 — — WO disclosed
Send feedback